Literature DB >> 30428735

Factors affecting effects of ultrasound guided high intensity focused ultrasound for single uterine fibroids: a retrospective analysis.

Hong-Jie Fan1, Jiang-Ping Cun1, Wei Zhao1, Jian-Qiang Huang1, Gen-Fa Yi1, Rui-Hong Yao1, Bu-Lang Gao1, Xing-Hai Li1.   

Abstract

OBJECTIVE: To investigate factors affecting effects of ultrasound guided high intensity focused ultrasound (USgHIFU) in the treatment of single uterine fibroids (UFs) with different magnetic resonance imaging (MRI) features.
METHODS: A total of 207 patients with single symptomatic UFs who were treated with HIFU were retrospectively analyzed. All UFs were grouped according to MRI features, and factors affecting HIFU ablation were set as independent variables. Non-perfusion volume ratio (NPVR) and energy efficiency factor (EEF) were set as dependent variables to establish multiple linear regression models with a stepwise method.
RESULTS: All patients had successful HIFU treatment, with the mean NPVR of 74.7 ± 15.1% and the mean EEF of 7.4 ± 5.2 j/mm3. The NPVR was negatively correlated with transmural type of UFs, hyperintense on T2 weighted image (T2WI), enhancement type on T1 weighted image (T1WI), distance from UFs ventral side to skin and posterior location of UFs, but positively correlated with anterior location of UFs, hypointense on T2WI and anteverted uterus (uterine location). The EEF was negatively correlated with size, anterior location of UFs and hypointense on T2WI, but positively correlated with distance from UFs ventral side to skin, enhancement type on T1WI and transmural type of UFs. The UFs size and enhancement type on T1WI were the greatest factors affecting the ablation effect.
CONCLUSIONS: The effect of HIFU treatment for single UFs is affected by multiple factors, and the UFs of hypointense on T2WI, large size, mild enhancement on T1WI and anteverted uterus can be easily ablated with high ablation efficiency.

Entities:  

Keywords:  High intensity focused ultrasound; affecting factors; energy efficiency factor; non-perfusion volume ratio; single uterine fibroids

Mesh:

Year:  2018        PMID: 30428735     DOI: 10.1080/02656736.2018.1511837

Source DB:  PubMed          Journal:  Int J Hyperthermia        ISSN: 0265-6736            Impact factor:   3.914


  6 in total

1.  Multifunctional Nanoparticles Encapsulating Astragalus Polysaccharide and Gold Nanorods in Combination with Focused Ultrasound for the Treatment of Breast Cancer.

Authors:  Jie Xiong; Binglei Jiang; Yong Luo; Jianzhong Zou; Xuan Gao; Die Xu; Yan Du; Lan Hao
Journal:  Int J Nanomedicine       Date:  2020-06-12

2.  Comparison of Dose and Effectiveness of a Single-Session Ultrasound-Guided High-Intensity Focused Ultrasound Ablation of Uterine Fibroids With Different Sizes.

Authors:  Mei-Jie Yang; Ren-Qiang Yu; Jin-Yun Chen; Zhi-Biao Wang
Journal:  Front Oncol       Date:  2021-12-21       Impact factor: 6.244

3.  Prediction of Clinical Outcome for High-Intensity Focused Ultrasound Ablation of Uterine Leiomyomas Using Multiparametric MRI Radiomics-Based Machine Leaning Model.

Authors:  Yineng Zheng; Liping Chen; Mengqi Liu; Jiahui Wu; Renqiang Yu; Fajin Lv
Journal:  Front Oncol       Date:  2021-09-10       Impact factor: 6.244

4.  Should Ultrasound-Guided High Frequency Focused Ultrasound Be Considered as an Alternative Non-Surgical Treatment of Uterine Fibroids in Non-Asiatic Countries? An Opinion Paper.

Authors:  Luz Angela Torres-de la Roche; Sarah Rafiq; Rajesh Devassy; Hugo Christian Verhoeven; Sven Becker; Rudy Leon De Wilde
Journal:  J Clin Med       Date:  2022-02-05       Impact factor: 4.241

5.  Physician Experience in Technical Success of Achieving NPVR ≥ 80% of High-Intensity Focused Ultrasound Ablation for Uterine Fibroids: A Multicenter Study.

Authors:  Xue Gong; Xinyue Zhang; Dang Liu; Chao Yang; Rong Zhang; Zhibo Xiao; Wenzhi Chen; Jinyun Chen
Journal:  Front Med Technol       Date:  2022-03-08

6.  A Prediction of NPVR ≥ 80% of Ultrasound-Guided High-Intensity Focused Ultrasound Ablation for Uterine Fibroids.

Authors:  Mei-Jie Yang; Ren-Qiang Yu; Wen-Zhi Chen; Jin-Yun Chen; Zhi-Biao Wang
Journal:  Front Surg       Date:  2021-06-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.